0.6342
Metavia Inc stock is traded at $0.6342, with a volume of 16,360.
It is down -1.98% in the last 24 hours and down -0.06% over the past month.
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
See More
Previous Close:
$0.647
Open:
$0.618
24h Volume:
16,360
Relative Volume:
0.14
Market Cap:
$15.35M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.43%
1M Performance:
-0.06%
6M Performance:
-56.56%
1Y Performance:
+0.00%
Metavia Inc Stock (MTVA) Company Profile
Name
Metavia Inc
Sector
Industry
Phone
(857) 702-9600
Address
545 CONCORD AVENUE, CAMBRIDGE
Compare MTVA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
MTVA
Metavia Inc
|
0.6342 | 15.66M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Metavia Inc Stock (MTVA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-30-24 | Initiated | H.C. Wainwright | Buy |
Metavia Inc Stock (MTVA) Latest News
What the charts say about MetaVia Inc. today2025 Market Sentiment & Free Community Consensus Stock Picks - Newser
Is MetaVia Inc. stock poised for growthPortfolio Update Report & Technical Confirmation Alerts - Newser
Visual analytics tools that track MetaVia Inc. performanceJuly 2025 Volume & Real-Time Stock Price Movement Reports - Newser
How hedge fund analytics apply to MetaVia Inc. stock2025 Top Gainers & Low Risk Entry Point Guides - Newser
Key metrics from MetaVia Inc.’s quarterly data2025 Top Decliners & Intraday High Probability Alerts - Newser
Will MetaVia Inc. outperform the marketQuarterly Trade Report & Weekly Setup with High ROI Potential - Newser
MetaVia Inc. stock daily chart insightsWeekly Trading Summary & Community Verified Trade Signals - Newser
What high frequency data says about MetaVia Inc.2025 Earnings Impact & Community Driven Trade Alerts - Newser
Backtesting results for MetaVia Inc. trading strategies2025 Risk Factors & AI Based Buy and Sell Signals - Newser
Applying big data sentiment scoring on MetaVia Inc.Bond Market & Fast Entry Momentum Trade Alerts - Newser
Using data models to predict MetaVia Inc. stock movementJuly 2025 Action & Precise Swing Trade Entry Alerts - Newser
Sector Rotation Brings MetaVia Inc. Into Focus2025 EndofYear Setup & Reliable Trade Execution Plans - beatles.ru
MetaVia Inc. Building a Base Near Support getLinesFromResByArray error: size == 0 - sisain.net
Can MetaVia Inc. hit a new high this monthPortfolio Risk Report & Comprehensive Market Scan Insights - Newser
Analyzing recovery setups for MetaVia Inc. investors2025 Short Interest & Comprehensive Market Scan Insights - Newser
MetaVia Inc. stock volume spike explainedWeekly Market Summary & Long-Term Growth Stock Strategies - Newser
How to interpret RSI for MetaVia Inc. stockWeekly Profit Recap & Precise Swing Trade Entry Alerts - Newser
Using RSI to spot recovery in MetaVia Inc.Trade Volume Report & Reliable Volume Spike Trade Alerts - Newser
Top chart patterns to watch in MetaVia Inc.Trade Exit Summary & Technical Confirmation Trade Alerts - Newser
Metavia Inc Stock (MTVA) Financials Data
There is no financial data for Metavia Inc (MTVA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Metavia Inc Stock (MTVA) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
DONG-A ST CO., LTD | 10% Owner |
May 08 '25 |
Buy |
0.71 |
4,647,887 |
3,300,000 |
9,995,679 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):